Welcome to our dedicated page for Healthpeak Properties news (Ticker: PEAK), a resource for investors and traders seeking the latest updates and insights on Healthpeak Properties stock.
Healthpeak Properties, Inc. (NYSE: PEAK), an S&P 500 healthcare REIT, maintains this centralized news hub for investors and industry professionals tracking its life science, medical office, and senior housing real estate portfolio. Find authoritative updates on strategic developments, financial performance, and sustainability initiatives that shape this leading healthcare property owner's market position.
This resource aggregates essential announcements including earnings reports, partnership agreements like the Callan Ridge life science campus development, and environmental stewardship milestones. Users gain insights into Healthpeak's tenant relationships, asset management strategies, and balance sheet strength through verified press releases and objective analysis.
Key updates across Healthpeak's three core sectors: Life Science facility expansions, Medical Office leasing activity, and Senior Housing operational trends. Discover how the company initiatives like LEED-certified developments align with broader healthcare real estate demands.
Bookmark this page for streamlined access to material disclosures about one of healthcare REITs' most diversified portfolios. Check regularly for updates on Healthpeak's disciplined capital allocation and growth strategies in essential healthcare infrastructure markets.
Healthpeak Properties reported first-quarter 2022 results, featuring a net income of $0.13 per share and Nareit FFO of $0.45 per share. Key highlights include:
- Same-Store Portfolio Cash NOI growth of 5.6%
- 263,000 square feet of Class A life science developments placed in service, totaling $262 million
- Liquidity of $2.1 billion and a net debt to adjusted EBITDA ratio of 5.1x
- Quarterly dividend declared at $0.30 per share
Guidance for 2022 remains unchanged, projecting earnings per share between $0.58 and $0.64.
Healthpeak Properties (NYSE: PEAK) declared a quarterly dividend of $0.30 per share. This dividend will be distributed on May 20, 2022, to shareholders recorded as of May 9, 2022. As a fully integrated real estate investment trust, Healthpeak focuses on high-quality healthcare real estate assets, including Life Science, Medical Office, and CCRC. This announcement reflects the company's commitment to returning capital to shareholders while maintaining a strong growth trajectory.
Healthpeak Properties, Inc. (NYSE: PEAK) will report its first quarter 2022 financial results post-market on May 3, 2022. A conference call and webcast to discuss these results will take place on May 4, 2022, at 9:00 a.m. MT (11:00 a.m. ET). Investors can access the call via dial-in numbers or online. Healthpeak is a leading real estate investment trust focusing on private-pay healthcare assets, including Life Science, Medical Office, and CCRCs. More details can be found on www.healthpeak.com.
Healthpeak Properties (NYSE: PEAK) will have its CEO, Tom Herzog, present at the Citi 2022 Global Property CEO Conference on March 8, 2022, at 5:00 p.m. Eastern Time. Interested parties can access the presentation via a webcast on Healthpeak's website, with a replay available until March 8, 2023. Healthpeak is a fully integrated REIT focused on high-quality real estate in the healthcare sector, including Life Science, Medical Office, and CCRCs. For more details, visit www.healthpeak.com.
Healthpeak Properties (NYSE: PEAK) announced the completion of long-term leases with Graphite Bio and another biotech firm for its Nexus on Grand project in South San Francisco, achieving 100% pre-leasing before completion. The development spans 148,000 square feet and is designed for advanced lab and office use, featuring modern amenities. This project, expected to be completed by Q2 2023, reflects strong market demand for specialized laboratory facilities.
Healthpeak Properties reported Q4 2021 net income of $0.05 per share and Nareit FFO of $0.41 per share. The company achieved blended Total Same-Store Portfolio Cash NOI growth of 2.7%, with life sciences experiencing a growth of 5.4%. In full-year 2021, net income reached $0.93 per share, though Nareit FFO declined from $1.30 to $1.12 per share. The company engaged in $1.5 billion in acquisitions and commenced four life science projects worth $812 million. A quarterly dividend of $0.30 per share was announced, payable on February 22, 2022. 2022 guidance reflects diluted earnings per share of $0.58 - $0.64.
Healthpeak Properties (NYSE: PEAK) announced a quarterly cash dividend of $0.30 per share, payable on February 22, 2022. Stockholders on record as of February 11, 2022 will receive the dividend. Healthpeak is a fully integrated real estate investment trust specializing in healthcare real estate across Life Science, Medical Office, and CCRCs. The company's strategic focus on long-term growth through high-quality real estate positions it well within the private-pay healthcare sector.
Healthpeak Properties, Inc. (NYSE: PEAK) will report its fourth quarter and year-end 2021 financial results after the NYSE trading on February 8, 2022. A conference call and webcast will take place on February 9, 2022, at 9:00 a.m. MT (11:00 a.m. ET) to discuss the financial performance and operating results. The dial-in number for U.S. participants is (888) 317-6003, with an international line at (412) 317-6061. Access the conference via webcast at Healthpeak's website. An archive will be available for a year.
Healthpeak Properties has priced a public green bond offering of $500 million in 2.125% senior unsecured notes due 2028. The offering price is 99.398% of the principal amount, with estimated net proceeds of approximately $492.4 million. The funds will finance eligible green projects or repay debt, including revolving credit and commercial paper. The offering is set to close on November 24, 2021.
FAQ
What is the market cap of Healthpeak Properties (PEAK)?
